Aligos Therapeutics, Inc. (ALGS)

CIK 1799448 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aligos Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 6, 202610-Q0001193125-26-336851
Aug 6, 20268-K0001171843-26-005294
Aug 6, 2026S-80001193125-26-337937
Jun 29, 202640001610717-26-000302
Jun 29, 202640001610717-26-000305
Jun 29, 202640001610717-26-000303
Jun 29, 202640001610717-26-000304
Jun 29, 202640001610717-26-000300
Jun 29, 202640001610717-26-000301
Jun 26, 20268-K0001193125-26-285426
Jun 24, 2026SCHEDULE 13D0001193125-26-281134
May 15, 2026SCHEDULE 13G/A0000919574-26-003231
May 15, 2026SCHEDULE 13G0001193125-26-226938
May 7, 20268-K0001171843-26-003156
May 7, 202610-Q0001193125-26-212001
Apr 29, 2026ARS0001193125-26-191897
Apr 29, 2026DEFA14A0001193125-26-191940
Apr 29, 2026DEF 14A0001193125-26-191843
Apr 21, 20268-K0001193125-26-166987
Apr 14, 20268-K0001193125-26-154927
Mar 11, 202640001610717-26-000093
Mar 11, 202640001610717-26-000094
Mar 11, 202640001610717-26-000092
Mar 11, 202640001610717-26-000095
Mar 5, 2026S-80001193125-26-092647